Gene therapy: Novel targets for congenital blindness
Wednesday, September 2, 2020 - 11:11
in Health & Medicine
Retinitis pigmentosa is the most prevalent form of congenital blindness. Using a retinitis pigmentosa mouse model, researchers have now shown that targeted activation of genes of similar function can compensate for the primary defect.